Efficacy of Pentoxifylline on Rapidly Progressive Glomerulonephritis
Status:
Terminated
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
We have recently demonstrated that pentoxifylline (PTX) has the potential to treat severe
glomerular inflammation in a rat model of accelerated anti-glomerular basement membrane (GBM)
glomerulonephritis. This study aims to investigate the therapeutic effects of combined PTX
and conventional immunosuppressive regimens on patients with rapidly progressive
glomerulonephritis.